Continuous Use of the Contraceptive Patch and the Personal Economic Impact.
NCT00357981 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2013-08-29
Summary
Dr. Eleanor Drey in the Department of Obstetrics, Gynecology and Reproductive Sciences UCSF is conducting a study to examine the personal and economic impact of continuous use of ORTHO EVRA, the contraceptive patch, on menstrual related symptoms for women who report having severe menstrual related symptoms.
Conditions
- Dysmenorrhea
- Menstruation Disturbances
- Menstruation Disorders
Interventions
- DRUG
-
ORTHO EVRA, the contraceptive patch
Sponsors & Collaborators
-
Ortho-McNeil, Inc.
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Eleanor Drey, MD, EdM · University of California, San Francisco
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
More Related Trials
-
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
NCT00781456 ·Status: COMPLETED ·Phase: PHASE2
-
Medical Treatment of Endometriosis-Associated Pelvic Pain
NCT00229996 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity
NCT00439972 ·Status: UNKNOWN ·Phase: PHASE2
-
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT00361400 ·Status: COMPLETED
-
Efficacy Trial of CDB 2914 for Emergency Contraception
NCT00271583 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigation of Female Reproductive Hormone Dynamics During Adolescence
NCT02486757 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Birth Control Patch Study
NCT00984789 ·Status: COMPLETED ·Phase: PHASE3
-
Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
NCT00393198 ·Status: COMPLETED ·Phase: PHASE4
-
Depot Medroxyprogesterone Acetate as Emergency Contraception
NCT03395756 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion
NCT06891794 ·Status: RECRUITING ·Phase: NA
-
The Aim of This Study is to Estimate the Discontinuation Rate of Low-dose Levonorgestrel-releasing Intrauterine System Due to Self-reported Unacceptable Menstrual Bleeding Pattern in Spanish Women Who Are Using it for the First Time How Intrauterine System for Long Acting Contraception
NCT04785950 ·Status: COMPLETED
-
Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch
NCT06048536 ·Status: COMPLETED ·Phase: PHASE2
-
US Cycle Control and Blood Pressure Study
NCT00920985 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of LevoCept
NCT02882191 ·Status: COMPLETED ·Phase: PHASE2
-
Transdermal Contraceptive Patch - Endometrial Effects Study
NCT00896571 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial
NCT00474851 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
NCT00195559 ·Status: COMPLETED ·Phase: PHASE3
-
Contraception Initiation Feasibility in the Pediatric ED
NCT03559634 ·Status: COMPLETED ·Phase: NA
-
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
NCT00360490 ·Status: COMPLETED ·Phase: PHASE3
-
Stopping Heavy Periods Project
NCT02002260 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.
NCT01204190 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
NCT00261482 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
NCT03296098 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
NCT06672016 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3